This project assessed changes in opioid use disorder (OUD) treatment utilization and expenditures in the employer-sponsored private health insurance market during 2007 and 2014. These years mark periods before and after implementation of major federal legislation enacted to increase insurance coverage and expand access to coverage of behavioral health care, the introduction and expanded use of new opioid treatment medications, and other initiatives to expand substance use disorder treatment access.
"MATOOP.pdf" (pdf, 3.07Mb)
Note: Documents in PDF format require the Adobe Acrobat Reader®. If you experience problems with PDF documents, please download the latest version of the Reader®